Disease-associated sequence variations in factor H: A structural biology approach

Advances in Experimental Medicine and Biology

Volumn 586, Issue , 2006, Pages 313-327

  Herbert, Andrew P ^a,b   Soares, Dinesh C ^a   Pangburn, Michael K ^b   Barlow, Paul N ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934437828     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-34134-X_21     Document Type: Conference Paper

References (57)

1. M. J. Walport, Complement. First of two parts, N Engl J Med 344(14), 1058-1066 (2001).
2. M. J. Walport, Complement. Second of two parts, N Engl J Med 344(15), 1140-1144 (2001).
3. P. Warwicker, T. H. Goodship, R. L. Donne, Y. Pirson, A. Nicholls, R. M. Ward, P. Turnpenny, and J. A. Goodship, Genetic studies into inherited and sporadic hemolytic uremic syndrome, Kidney Int 53(4), 836-844 (1998).
4. T. Goodship, Inherited dysregulation of the complement system, Bull Mem Acad R Med Belg 159(Pt 2), 195-198 (2004).
5. R. J. Klein, C. Zeiss, E. Y. Chew, J. Y. Tsai, R. S. Sackler, C. Haynes, A. K. Henning, J. P. SanGiovanni, S. M. Mane, S. T. Mayne, M. B. Bracken, F. L. Ferris, J. Ott, C. Barnstable, and J. Hoh, Complement factor H polymorphism in age-related macular degeneration, Science 308(5720), 385-389 (2005).
6. J. L. Haines, M. A. Hauser, S. Schmidt, W. K. Scott, L. M. Olson, P. Gallins, K. L. Spencer, S. Y. Kwan, M. Noureddine, J. R. Gilbert, N. Schnetz-Boutaud, A. Agarwal, E. A. Postel, and M. A. Pericak-Vance, Complement factor H variant increases the risk of age-related macular degeneration, Science 308(5720), 419-421 (2005).
7. G. S. Hageman, D. H. Anderson, L. V. Johnson, L. S. Hancox, A. J. Taiber, L. I. Hardisty, J. L. Hageman, H. A. Stockman, J. D. Borchardt, K. M. Gehrs, R. J. Smith, G. Silvestri, S. R. Russell, C. C. Klaver, I. Barbazetto, S. Chang, L. A. Yannuzzi, G. R. Barile, J. C. Merriam, R. T. Smith, A. K. Olsh, J. Bergeron, J. Zernant, J. E. Merriam, B. Gold, M. Dean, and R. Allikmets, A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration, Proc Natl Acad Sci USA 102(20), 7227-7232 (2005).
8. A. O. Edwards, R. Ritter 3rd, K. J. Abel, A. Manning, C. Panhuysen, and L. A. Farrer, Complement factor H polymorphism and age-related macular degeneration, Science 308(5720), 421-424 (2005).
9. P. N. Barlow, D. G. Norman, A. Steinkasserer, T. J. Horne, J. Pearce, P. C. Driscoll, R. B. Sim, and I. D. Campbell, Solution structure of the fifth repeat of factor H: a second example of the complement control protein module, Biochemistry 31(14), 3626-3634 (1992).
10. P. N. Barlow, A. Steinkasserer, D. G. Norman, B. Kieffer, A. P. Wiles, R. B. Sim, and I. D. Campbell, Solution structure of a pair of complement modules by nuclear magnetic resonance, J Mol Biol 232(1), 268-284 (1993).
11. D. G. Norman, P. N. Barlow, M. Baron, A. J. Day, R. B. Sim, and I. D. Campbell, Three-dimensional structure of a complement control protein module in solution, J Mol Biol 219(4), 717-725 (1991).
12. K. B. Reid and A. J. Day, Structure-function relationships of the complement components, Immunol Today 10(6), 177-180 (1989).
13. A. Richards, E. J. Kemp, M. K. Liszewski, J. A. Goodship, A. K. Lampe, R. Decorte, M. H. Muslumanoglu, S. Kavukcu, G. Filler, Y. Pirson, L. S. Wen, J. P. Atkinson, and T. H. Goodship, Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome, Proc Natl Acad Sci USA 100(22), 12966-12971 (2003).
14. D. Kavanagh, E. J. Kemp, E. Mayland, R. J. Winney, J. S. Duffield, G. Warwick, A. Richards, R. Ward, J. A. Goodship, and T. H. Goodship, Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome, J Am Soc Nephrol 16(7), 2150-2155 (2005).
15. R. B. Sim, and R. G. DiScipio, Purification and structural studies on the complement-system control protein beta 1H (Factor H), Biochem J 205(2), 285-293 (1982).
16. J. Rey-Campos, D. Baeza-Sanz, and S. Rodriguez de Cordoba, Physical linkage of the human genes coding for complement factor H and coagulation factor XIII B subunit, Genomics 7(4), 644-646 (1990).
17. J. Rey-Campos, P. Rubinstein, and S. Rodriguez de Cordoba, A physical map of the human regulator of complement activation gene cluster linking the complement genes CR1, CR2, DAF, and C4BP, J Exp Med 167(2), 664-669 (1988).
18. D. Heine-Suner, M. A. Diaz-Guillen, F. P. de Villena, M. Robledo, J. Benitez, and S. Rodriguez de Cordoba, A high-resolution map of the regulator of the complement activation gene cluster on 1q32 that integrates new genes and markers, Immunogenetics 45(6), 422-427 (1997).
19. D. C. Soares, D. L. Gerloff, N. R. Syme, A. F. Coulson, J. Parkinson, and P. N. Barlow, Large-scale modelling as a route to multiple surface comparisons of the CCP module family, Protein Eng Des Sel 18(8), 379-388 (2005).
20. J. Krushkal, O. Bat, and I. Gigli, Evolutionary relationships among proteins encoded by the regulator of complement activation gene cluster, Mol Biol Evol 17(11), 1718-1730 (2000).
21. D. C. Soares, and P. N. Barlow, Complement control protein modules in the regulators of complement activation, in: Structural biology of the complement System, edited by D. Morikis and J. D. Lambris (Taylor & Francis, Boca Raton, Florida, 2005), pp. 19-62.
22. R. G. DiScipio, Ultrastructures and interactions of complement factors H and I, J Immunol 149(8), 2592-2599 (1992).
23. M. Aslam, and S. J. Perkins, Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultra-centrifugation and constrained molecular modelling, J Mol Biol 309(5), 1117-1138 (2001).
24. T. S. Jokiranta, J. Hellwage, V. Koistinen, P. F. Zipfel, and S. Meri, Each of the three binding sites on complement factor H interacts with a distinct site on C3b, J Biol Chem 275(36), 27657-27662 (2000).
25. P. F. Zipfel, C. Skerka, J. Hellwage, S. T. Jokiranta, S. Meri, V. Brade, P. Kraiczy, M. Noris, and G. Remuzzi, Factor H family proteins: on complement, microbes and human diseases, Biochem Soc Trans 30(Pt 6), 971-978 (2002).
26. M. K. Pangburn, M. A. Atkinson, and S. Meri, Localization of the heparin-binding site on complement factor H, J Biol Chem 266(25), 16847-16853 (1991).
27. R. Pio, A. Martinez, E. J. Unsworth, J. A. Kowalak, J. A. Bengoechea, P. F. Zipfel, T. H. Elsasser, and F. Cuttitta, Complement factor H is a serum-binding protein for adrenomedullin, and the resulting complex modulates the bioactivities of both partners, J Biol Chem 276(15), 12292-12300 (2001).
28. R. Malhotra, M. Ward, R. B. Sim, and M. I. Bird, Identification of human complement Factor H as a ligand for L-selectin, Biochem J 341(Pt 1), 61-69 (1999).
29. H. Jarva, T. S. Jokiranta, J. Hellwage, P. F. Zipfel, and S. Meri, Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11, J Immunol 163(7), 3957-3962 (1999).
30. C. M. Taylor, Hemolytic-uremic syndrome and complement factor H deficiency: clinical aspects, Semin Thromb Hemost 27(3), 185-190 (2001).
31. D. P. Blackall, and M. B. Marques, Hemolytic uremic syndrome revisited: Shiga toxin, factor H, and fibrin generation, Am J Clin Pathol 121(Suppl), S81-88 (2004).
32. M. R. Buddles, R. L. Donne, A. Richards, J. Goodship, and T. H. Goodship, Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome, Am J Hum Genet 66(5), 1721-1722 (2000).
33. J. Caprioli, F. Castelletti, S. Bucchioni, P. Bettinaglio, E. Bresin, G. Pianetti, S. Gamba, S. Brioschi, E. Daina, G. Remuzzi, and M. Noris, Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease, Hum Mol Genet 12(24), 3385-3395 (2003).
34. M. A. Dragon-Durey, V. Fremeaux-Bacchi, C. Loirat, J. Blouin, P. Niaudet, G. Deschenes, P. Coppo, W. Herman Fridman, and L. Weiss, Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases, J Am Soc Nephrol 15(3), 787-795 (2004).
35. A. Richards, M. R. Buddles, R. L. Donne, B. S. Kaplan, E. Kirk, M. C. Venning, C. L. Tielemans, J. A. Goodship, and T. H. Goodship, Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition, Am J Hum Genet 68(2), 485-490 (2001).
36. P. Sanchez-Corral, C. Gonzalez-Rubio, S. Rodriguez de Cordoba, and M. Lopez-Trascasa, Functional analysis in serum from atypical hemolytic uremic syndrome patients reveals impaired protection of host cells associated with mutations in factor H, Mol Immunol 41(1), 81-84 (2004).
37. B. H. Ault, Factor H and the pathogenesis of renal diseases, Pediatr Nephrol 14(10-11), 1045-1053 (2000).
38. D. Perez-Caballero, C. Gonzalez-Rubio, M. E. Gallardo, M. Vera, M. Lopez-Trascasa, S. Rodriguez de Cordoba, and P. Sanchez-Corral, Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome, Am J Hum Genet 68(2), 478-484 (2001).
39. J. Esparza-Gordillo, E. Goicoechea de Jorge, A. Buil, L. Carreras Berges, M. Lopez-Trascasa, P. Sanchez-Corral, and S. Rodriguez de Cordoba, Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32, Hum Mol Genet 14(5), 703-712 (2005).
40. M. Noris, S. Bucchioni, M. Galbusera, R. Donadelli, E. Bresin, F. Castelletti, J. Caprioli, S. Brioschi, F. Scheiflinger, and G. Remuzzi, Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement, J Am Soc Nephrol 16(5), 1177-1183 (2005).
41. L. V. Johnson, W. P. Leitner, M. K. Staples, and D. H. Anderson, Complement activation and inflammatory processes in Drusen formation and age related macular degeneration, Exp Eye Res 73(6), 887-896 (2001).
42. R. F. Mullins, N. Aptsiauri, and G. S. Hageman, Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis, Eye 15(Pt 3), 390-395 (2001).
43. H. M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T. N. Bhat, H. Weissig, I. N. Shindyalov, and P. E. Bourne, The Protein Data Bank, Nucleic Acids Res 28(1), 235-242 (2000).
44. S. F. Altschul, W. Gish, W. Miller, E. W. Myers, and D. J. Lipman, Basic local alignment search tool, J Mol Biol 215(3), 403-410 (1990).
45. A. Sali, and T. L. Blundell, Comparative protein modelling by satisfaction of spatial restraints, J Mol Biol 234(3), 779-815 (1993).
46. L. J. McGuffin, K. Bryson, and D. T. Jones, The PSIPRED protein structure prediction server, Bioinformatics 16(4), 404-405 (2000).
47. M. J. Bower, F. E. Cohen, and R. L. Dunbrack, Jr., Prediction of protein side-chain rotamers from a backbone-dependent rotamer library: a new homology modeling tool, J Mol Biol 267(5), 1268-1282 (1997).
48. R. A. Laskowski, M. W. MacArthur, D. S. Moss, and J. M. Thornton, PROCHECK: a program to check the stereochemical quality of protein structures, J Appl Cryst 26, 283-291 (1993).
49. M. J. Lehtinen, H. Hagglund, and T. S. Jokiranta, Reason for the association between factor H mutations and atypical hemolytic-uremic syndrome is not in all cases impaired heparin binding of the mutant protein. Mol Immunol 43, 166 (2006).
50. B. H. Ault, B. Z. Schmidt, N. L. Fowler, C. E. Kashtan, A. E. Ahmed, B. A. Vogt, and H. R. Colten, Human factor H deficiency. Mutations in framework cysteine residues and block in H protein secretion and intracellular catabolism, J Biol Chem 272(40), 25168-25175 (1997).
51. H. P. Neumann, M. Salzmann, B. Bohnert-Iwan, T. Mannuelian, C. Skerka, D. Lenk, B. U. Bender, M. Cybulla, P. Riegler, A. Konigsrainer, U. Neyer, A. Bock, U. Widmer, D. A. Male, G. Franke, and P. F. Zipfel, Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries, J Med Genet 40(9), 676-681 (2003).
52. R. E. Saunders, and S. J. Perkins, A website for factor H-associated haemolytic uraemic syndrome and disease-associated mutations. Session 14: Novel roles of complement regulators and receptors. Immunology 113(s1), 73-79 (2004).
53. G. Remuzzi, P. Ruggenenti, D. Codazzi, M. Noris, J. Caprioli, G. Locatelli, and B. Gridelli, Combined kidney and liver transplantation for familial haemolytic uraemic syndrome, Lancet 359(9318), 1671-1672 (2002).
54. S. Rodriguez de Cordoba, J. Esparza-Gordillo, E. Goicoechea de Jorge, M. Lopez-Trascasa, and P. Sanchez-Corral, The human complement factor H: functional roles, genetic variations and disease associations, Mol Immunol 41(4), 355-367 (2004).
55. S. J. Perkins, and T. H. Goodship, Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site, J Mol Biol 316(2), 217-224 (2002).
56. J. Caprioli, P. Bettinaglio, P. F. Zipfel, B. Amadei, E. Daina, S. Gamba, C. Skerka, N. Marziliano, G. Remuzzi, and M. Noris, The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20, J Am Soc Nephrol 12(2), 297-307 (2001).
57. P. Sanchez-Corral, D. Perez-Caballero, O. Huarte, A. M. Simckes, E. Goicoechea, M. Lopez-Trascasa, and S. R. de Cordoba, Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome, Am J Hum Genet 71(6), 1285-1295 (2002).